Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal bupivacaine versus ropivacaine for elective caesarean section spinal anaesthesia
IRCT20190506043495N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of bupivacaine and ropivacaine in None (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Age, Drug group and 10 more. Started May 2019; status: completed.
02
Drugs
bupivacaineropivacaine
Beyond the preview
Go deeper on IRCT20190506043495N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190506043495N1.